Notice of Intent to Sole Source – 10x Genomics, Inc.

The National Institutes of Health, through its Office of Purchasing and Contracts, intends to sole source a firm fixed-price contract to 10X Genomics Inc. for reagents and consumables essential to the Early Detection of Lung Diseases project. This action is authorized under FAR Part 13 Simplified Acquisition Procedures, which permits non-competitive contracts when only one source is reasonably available and the value does not exceed the simplified acquisition threshold, thereby exempting the procurement from standard competition requirements. The acquisition supports critical research within the Critical Care Medicine Department and is specifically targeted to ensure access to proprietary technology necessary for the project’s success. This notice serves solely as an announcement of intent and does not constitute a solicitation or request for quotations; no formal bidding process will be conducted. Interested parties may submit comments referencing solicitation number NOI-OD-26-007025 prior to the specified close date to Ryssa Nix, Contract Specialist, at [email hidden]. The contract will be performed at the NIH Clinical Center in Bethesda, Maryland, with the NAICS code 541715 reflecting its classification within scientific research and development services. The posting date is July 24, 2026, and all correspondence must be directed to the designated point of contact.